Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jun 12:15:1440394.
doi: 10.3389/fimmu.2024.1440394. eCollection 2024.

Editorial: Liquid biopsies in hematological malignancies

Susana García-Silva  1 , Dario Marchetti  2 , Miguel Gallardo  3
Affiliations
Editorial

Editorial: Liquid biopsies in hematological malignancies

Susana García-Silva et al. Front Immunol. .
No abstract available

Keywords: hematological malignancies; immunotherapy; liquid biopsies; minimal residual disease (MRD); next-generation sequence (NGS).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Liquid biopsies in hematological malignancies

References

    1. Markou A, Tzanikou E, Lianidou E. The potential of liquid biopsy in the management of cancer patients. Semin Cancer Biol. (2022) 84:69–79. doi: 10.1016/j.semcancer.2022.03.013 - DOI - PubMed
    1. Cescon DW, Bratman SV, Chan SM, Siu LL, Circulating tumor DNA. and liquid biopsy in oncology. Nat Cancer. (2020) 1:276–90. doi: 10.1038/s43018-020-0043-5 - DOI - PubMed
    1. Trino S, Lamorte D, Caivano A, De Luca L, Sgambato A, Laurenzana I. Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy. Leukemia. (2021) 35:661–78. doi: 10.1038/s41375-020-01104-1 - DOI - PMC - PubMed
    1. Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic - implementation issues and future challenges. Nat Rev Clin Oncol. (2021) 18:297–312. doi: 10.1038/s41571-020-00457-x - DOI - PubMed
    1. Pantel K, Alix-Panabieres C. Liquid biopsy and minimal residual disease - latest advances and implications for cure. Nat Rev Clin Oncol. (2019) 16:409–24. doi: 10.1038/s41571-019-0187-3 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources